If you have been reading about freeze-thaw and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-06-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Practical handling often includes dividing a reconstituted solution into single-use aliquots to limit freeze-thaw cycling. Vials made of low-binding plastic or glass with inert closures are common, and some protocols add a carrier protein or bulking agent to reduce adsorption. Filtration through a sterile filter may be used when a sterile solution is required, but filters can retain peptide if binding occurs. Mixing is usually gentle; vigorous vortexing can introduce air-liquid interfaces that promote aggregation. Each of these steps involves trade-offs between sterility, recovery, and analytical accuracy.
Storage recommendations for reconstituted peptides vary by sequence and intended use, so general rules remain broad. A common laboratory practice is to keep solutions cold, sometimes frozen, and protected from light, but freezing itself can damage certain peptides. The pH of the solution may be adjusted to a range where the peptide is most stable, though changing pH can also alter solubility. Documentation of reconstitution date, solvent, concentration, and storage conditions supports reproducibility. Stability data for a specific peptide are generally established by direct measurement rather than assumed from related compounds.
Quality verification after reconstitution may include visual inspection, pH measurement, and chromatographic analysis. Reverse-phase high-performance liquid chromatography can reveal degradation peaks, while mass spectrometry can confirm molecular identity. Concentration may be estimated from the weighed peptide mass or determined by amino acid analysis, UV absorbance, or quantitative chromatography. Documentation of solvent, volume, date, and storage conditions supports traceability and reproducibility. Records also help identify when a solution was prepared and whether it has exceeded an established in-house shelf life.
After a dried peptide is dissolved, the resulting solution is treated as a distinct material with its own stability profile. Temperature, pH, ionic strength, and peptide concentration all influence how long the solution remains suitable for its intended laboratory use. Some sequences are prone to oxidation, deamidation, or aggregation. Because these processes vary widely, no single storage condition applies to every peptide. Buffer composition and light exposure can also shift degradation rates.
Aseptic technique matters when the solution will contact cells or biological reagents. Working in a clean environment, using sterile liquids and containers, and minimizing open-vial time reduce the chance of microbial contamination. Filtration through a sterile filter can remove particles and microorganisms, but some filters adsorb peptides and some peptides are retained by certain membrane materials. Compatibility between the peptide, solvent, and filter should be checked when recovery is critical.
| Property | Value | Notes |
|---|---|---|
| Solution appearance | Clear to slightly opalescent | Cloudiness can signal aggregation or undissolved material. |
| Typical short-term storage | 2-8 °C | Refrigeration is common for solutions used within a short period. |
| Typical long-term storage | -20 °C or lower | Freezing may require aliquoting to avoid repeated freeze-thaw cycles. |
| Common container | Low-binding plastic or glass vial | Low-binding surfaces can reduce adsorptive loss. |
| Common preservative | Bacteriostatic water | Contains an antimicrobial agent; not compatible with all analytical workflows. |
Concentration calculations depend on the amount of peptide present in the vial and the volume of solvent added. Lyophilized preparations often contain counterions, salts, or residual water, so the labeled mass may not equal the mass of the peptide itself. This difference can produce a calculated concentration that is higher than the true peptide concentration. Analytical determination of peptide content, rather than reliance on the vial label alone, reduces this source of error. Uncertainty in volume measurement also contributes, especially when small liquid volumes are handled.
Quality records typically include a certificate of analysis, batch number, molecular weight, purity result, and recommended storage conditions. After reconstitution, a laboratory log may record solvent, final volume, date, and storage location. Such documentation supports reproducibility and allows later investigation if a preparation behaves unexpectedly. Stability studies often examine purity and concentration over time under defined temperatures, but results are not universally transferable between peptides or formulations. Open questions remain about how best to predict aggregation for specific sequences and how much analytical testing is sufficient for routine laboratory work.
Reconstitution is the process of adding a liquid to a lyophilized peptide so that the dried material dissolves into solution. Lyophilization removes water from a frozen peptide preparation under reduced pressure, leaving a porous solid or powder. The dried form often has greater long-term stability than a liquid because hydrolysis and oxidation are slowed. In laboratory work, reconstitution is usually the first step before dilution, analysis, or further experiments. The result is a stock solution whose concentration depends on the volume of solvent added and the amount of peptide in the vial.
Solvent choice depends on the peptide's sequence, charge, and solubility profile. Sterile water is common for freely soluble peptides, while aqueous buffers or dilute acid or base may be needed for others. Some sequences contain hydrophobic regions that resist water alone and require a small amount of organic co-solvent. The solvent's pH can affect charge state, aggregation, and stability. Because peptides vary widely, no single universal reconstitution liquid exists, and suppliers often provide a recommended solvent based on testing of a specific lot or sequence.
=== Complications === Pressure ulcers can trigger other ailments, cause considerable suffering, and can be expensive to treat. Some complications include autonomic dysreflexia, bladder distension, bone infection, pyarthrosis, sepsis, amyloidosis, anemia, urethral fistula, gangrene and very rarely malignant transformation (Marjolin's ulcer – secondary carcinomas in chronic wounds). Sores may recur if those with pressure ulcers do not follow recommended treatment or may instead develop seromas, hematomas, infections, or wound dehiscence. Paralyzed individuals are the most likely to have pressure sores recur. In some cases, complications from pressure sores can be life-threatening. The most common causes of fatality stem from kidney failure and amyloidosis. Pressure ulcers are also painful, with individuals of all ages and all stages of pressure ulcers reporting pain.
== Coding and Homology == The very first nucleotide sequence of the gene encoding for the beta subunit of human chorionic gonadotropin (CGB) suggests that CGB evolved from a duplicate copy of the beta subunit of LH, another glycoprotein hormone with significant influence over pregnancy, expressed in the anterior pituitary gland. Subsequent nuclear mapping has found that humans possess six copies of the CGB gene, amazingly found together with the LHB gene on chromosome 19q13.33. Human CGB and LHB genes share an extremely high degree of similarity in their sequences, clocking in at 94% similarity. This nucleotide sequence is encompassed by 3 exons. Of the six genes that encode for CGB, four of them are functional. These include CGB, CGB5, CGB7, and CGB8. These four genes share a 97-99% DNA sequence similarity, and code for the biochemically functional beta subunit of hCG. Although CGB1 and CGB2 genes are similar in sequence to the other four genes previously mentioned (85%), they encode for a novel hypothetical protein that is 132 amino acids in length and does not share any homology to the functional CGB subunit. This particular result was caused by a DNA fragment insertion into the 5' untranslated region (UTR) of the CGB1 and CGB2 genes, giving way to a novel exon one and creating a single basepair open reading frame shift for exons two and three.
24 June – David Hinton, the chief executive of South East Water, has blamed the increase in people working from home as a result of the COVID-19 pandemic for the implementation of a planned hosepipe ban on 26 June, with an estimated 20% increase in the use of drinking water in commuter towns. 25 June – Avon and Somerset Police confirm that a man in his 40s has died following a "medical incident" at the 2023 Glastonbury Festival. 26 June – An inquest opens into the death of Nicola Bulley. 27 June – The inquest into the death of Nicola Bulley returns a verdict of accidental death. Sarah Bentley resigns as chief executive of Thames Water after previously forgoing her bonus after raw sewage became a problem for the company. Nurses in England will not continue their strike action after a Royal College of Nursing ballot failed to garner enough votes to achieve a mandate. The majority of the 43% who voted favoured continued strike action, but this was below the 50% turnout required under trade union regulations. Senior consultants in England will begin strike action after 86% of those who took part in a ballot voted to take strike action; a previously announced 48-hour strike will now go ahead from 21 July. 28 June – The second Test match of the 2023 Ashes series is briefly interrupted when Just Stop Oil protestors invade the pitch at Lord's. Thames Water is reported to be in talks with the UK government to secure extra funding amid concerns the company is on the brink of collapse. 29 June – Sir John Mitting's interim report for the Undercover Policing Inquiry is published.
From Zunsser's view that "one cannot practice a profession like a trade" (p.157), he observed that, for instance, "an improvement in the mechanism of an automobile, or of a shoe buckle" — which were "matters of convenience or luxury", and therefore, "[could] be dispensed with easily by those who are forced to do without them" — were in an entirely "different category" from matters concerning "the relief of the sick and the prevention of unnecessary sorrow by the maintenance of individual and public health" which, "as soon as we are in possession of the knowledge of principles or methods which can contribute to these purposes their free utilization becomes a public necessity"; and, from this, he argued that "there is no valid argument in favor of the patenting of a useful method of preserving health, private or public, unless we admit [which Zinsser did not] that medical discoveries in no ethical sense differ from the purely commercial ones" (p.161). In addition to the question of whether it was ethical to patent medical inventions (pharmaceuticals, devices, apparatus, procedures, etc.), or not — in particular, whether "products of scientific research that affect public and individual health, particularly discoveries and inventions of a medical, pharmaceutical, therapeutic, or hygienic nature ...
==== Nocturnal enuresis ==== Children with OSA also show a higher risk for nocturnal enuresis and it is hypothesized to be caused by an excessive production of urine, impaired performance of the bladder and urethra or an inability to suppress the nocturnal bladder contraction, due to a failure to arouse. The risk for nocturnal enuresis increases with the severity of the sleep-disordered breathing: the more respiratory events per hour of sleep, the higher the risk for nocturnal enuresis. Obesity may also play a role, as it is associated with OSA and with nocturnal diuresis (due to an unhealthy diet). The interaction between OSA and obesity might thus result in nocturnal enuresis. Considering the high prevalence of nocturnal enuresis amongst children with sleep-disordered breathing, it is important to consider the latter in the differential diagnosis of nocturnal enuresis as the treatment of the sleep disorder might have a favourable therapeutic effect on the enuresis. For example, an adenotonsillectomy performed to reduce OSA has a positive impact on nocturnal enuresis. A study has shown that this surgery has a 60–75% chance to resolve the nocturnal enuresis completely, and an 80–85% chance to reduce its symptoms alongside other symptoms of OSA.
Sources: en.wikipedia.org
== Acquisitions == Bruker acquisitions include GE NMR Instruments (1992), Siemens AXS (1997), Nonius (2001), MacScience (2002), Vacuumschmelze Hanau (2003), Röntec (2005), SOCABIM (2005), PGT (2005), Keymaster (2006), Quantron (2006), JuWe (2008), SIS (2008), ACCEL (2009), Michrom Bioresources (2011), Skyscan (2012), Prairie Technologies (2013), Oncovision (Preclinical PET imaging business, 2016), Oxford Instruments Superconducting Technology (2016), Hysitron Inc. (2017), XGLab (2017), Luxendo (2017), JPK Instruments (2018), Alicona (2018), PMOD Technologies LLC (2019), Canopy Biosciences (2020), Optimal Group (2022), Neurescence Inc (2022), PhenomeX (2023), MIRO Analytical (majority 2023), NanoString Technologies assets (2024), and ELITechGroup (2024).
Eloralintide (LY3841136) is an experimental drug that works as a selective amylin receptor agonist. It was designed to activate the amylin receptor without off-target effects at the calcitonin receptor. In a recent US randomised controlled trial of obese patients (mean bodyweight 109 kg, mean BMI 39 kg/m2), those receiving the highest assessed dose showed a 20 percent reduction in body weight over the 48 week study period when compared to placebo.
Timothy C. Bates (born 1963) is a professor of differential psychology at the University of Edinburgh. His research interests include the genetics of reading and spelling, intelligence, and personality.
1993/2452) Restrictive Trade Practices (Standards and Arrangements) (Services) Order 1993 (S.I. 1993/2453) Sole (Specified Sea Areas) (Prohibition of Fishing) Order 1993 (S.I. 1993/2459) East Gloucestershire National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2460) Mulberry National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2461) Southampton Community Health Services National Health Service Trust (Transfer of Trust Property) Order 1993 (S.I. 1993/2462) London South Circular Trunk Road (A205)(London Road, Lewisham and Southwark) (Box Junction) Order 1993 (S.I. 1993/2463) London South Circular Trunk Road (A205) (Lordship Lane, Lewisham and Southwark) (Box Junction) Order 1993 (S.I. 1993/2464) Sole (Specified Sea Areas) (Prohibition of Fishing) (No. 2) Order 1993 (S.I. 1993/2465) Restrictive Trade Practices (Standards and Arrangements) (Goods) Order 1993 (S.I. 1993/2473) Road Traffic Accidents (Payments for Treatment) Order 1993 (S.I. 1993/2474) Income Tax (Interest Relief) (Qualifying Lenders) (No. 3) Order 1993 (S.I. 1993/2478) Offshore Installations (Safety Zones) (No. 4) Order 1993 (S.I. 1993/2479) Miscellaneous Factories (Transitional Provisions) Regulations 1993 (S.I. 1993/2482) Design Right (Semiconductor Topographies) (Amendment) Regulations 1993 (S.I. 1993/2497) Value Added Tax (Beverages) Order 1993 (S.I. 1993/2498) Smoke Control Areas (Authorised Fuels) (Amendment) Regulations 1993 (S.I. 1993/2499)
Sources: en.wikipedia.org
Their intention was to protect Raleigh from the destruction inflicted on other cities by Union troops. Graham and Swain departed to meet the advancing Federal forces on the morning of April 12, 1865, and were to return by that evening. The evening struck, but Graham and Swain had not returned due to train delays and their temporary capture by Sherman. Governor Vance left the evening after Graham and Sherman failed to return, leaving behind a letter giving Mayor William H. Harrison the authority to surrender. On the morning of April 13, Mayor Harrison among others went to the southern Wake County area to meet General Hugh Judson Kilpatrick and propose surrender. Kenneth Rayner, a long-time resident of Raleigh, delivered the proposal including a promise of no resistance. Kilpatrick agreed to accept the surrender and protect Raleigh from destruction. Kilpatrick's cavalry occupied Raleigh and removed the flagpole from the state capitol, replacing it with a United States Flag above the dome. Sherman arrived shortly after and established his headquarters in the governor's mansion. The city was spared significant destruction during the war. As Confederate cavalry retreated west, Union soldiers followed, leading to the Battle of Morrisville nearby. Due to the economic and social problems of the postwar period and Reconstruction, with a state economy still heavily dependent on agriculture, the city grew little over the next several decades. Shaw University, the South's first African American college, began classes in 1865 and was chartered in 1875.
Human serum albumin, osmolyte and carrier protein α-fetoprotein, the fetal counterpart of serum albumin Soluble plasma fibronectin, forming a blood clot that stops bleeding C-reactive protein, opsonin on microbes, acute phase protein Various other globulins
== Mosaic Diagnostics, formerly Great Plains Laboratory == William Shaw's laboratory is known for performing nonstandard tests which have been used by alternative medicine practitioners to support discredited diagnoses. Great Plains Laboratory's urine mycotoxin test is not validated nor recommended for diagnosing any condition. In May 2020, early in the COVID-19 pandemic, Great Plains marketed unproven antibody tests.
Sources: en.wikipedia.org
Storage time depends on peptide sequence, concentration, solvent, and temperature. No single shelf life applies to all peptides. Stability should be determined by analytical testing for the specific preparation.
Aliquots limit the number of freeze-thaw cycles a solution undergoes. Repeated temperature changes can cause aggregation, precipitation, or loss of peptide to container surfaces. Single-use portions also reduce contamination risk when handled aseptically.
Some amino acid side chains, such as tryptophan and tyrosine, can undergo photo-oxidation. Amber vials or foil wrapping are used to reduce light exposure in laboratory settings. The sensitivity varies widely among peptides.
Most reconstituted peptide solutions are kept cold, often at 2–8 °C for short-term use. Longer storage may require freezing at -20 °C or below, depending on the peptide. Repeated freeze-thaw cycles can promote aggregation or degradation.